Pretomanid
Pretomanid, Dovprela, Pretomanid FGK (pretomanid) is a small molecule pharmaceutical. Pretomanid was first approved as Pretomanid on 2019-08-14. It is used to treat extensively drug-resistant tuberculosis in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis.
| Trade Name | Dovprela, Pretomanid FGK |
|---|---|
| Common Name | Pretomanid |
| Indication | extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis |
| Drug Class | Mycolic acid inhibitors |
